BioGaia AB (publ)

BioGaia AB (publ)

BIOGY

$12.45

Updated: 24/09/2026, 11:39:35

Market Cap
$1.26B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
SE
Stock valuation chart
One-year closing share-price history for BIOGY
Company Profile

BioGaia AB (publ) is a global enterprise dedicated to the development, marketing, and sale of probiotic products, all backed by documented health benefits. The company organizes its activities into three primary divisions: Pediatrics, Adult Health, and 'Other'. Within the Pediatric segment, BioGaia provides items such as liquid drops, oral rehydration solutions, and gut health tablets, alongside supplying probiotic cultures for integration into infant formula. The Adult Health segment offers both digestive health tablets and oral hygiene lozenges, as well as providing cultures that are incorporated into dairy products by its licensees. The 'Other' segment focuses on delivering packaging solutions. BioGaia's product portfolio addresses a wide array of health conditions, including infantile colic and digestive problems in children, acute and antibiotic-associated diarrhea, gingivitis, periodontal disease, general wellness, Helicobacter pylori infections (the bacterium causing gastric ulcers), and low bone density. All of the company's products are sold under the BioGaia brand. Founded in 1990, BioGaia AB (publ) is headquartered in Stockholm, Sweden.

USD
OTC
CEO: Theresa Agnew
Employees: 242
https://www.biogaiagroup.com
Asset Summaries
Latest generated summaries for BIOGY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for BIOGY.
Share price
$12.45
Market cap
$1.26B
Exchange
OTC
Currency
USD
CEO
Theresa Agnew
Employees
242
IPO date
08/01/2021
Beta
0.319
Last dividend
$0.00
Day range
$12.35 – $12.45
52-week range
$9.64 – $12.45
1-day performance
0.00%
1-year performance
29.15%
Current drawdown (1Y)
0.00%
CIK
0001572957
CUSIP
09072J102
ISIN
US09072J1025
Created
07/12/2025, 03:00:01
Last update
24/09/2026, 11:39:35

Track BioGaia AB (publ) with an AI analyst

See which prediction-market events move BIOGY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to BIOGY from your Railway `news_articles` table.

No news found for this symbol.